About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide
- Procedure number
- PSUSA/00010374/202101
- Regulatory outcome
- Variation
Documents
Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide : List of nationally authorised medicinal products - PSUSA/00010374/202101
English (EN) (166.81 KB - PDF)
Amitriptyline, amitriptyline / amitriptylinoxide, amitriptylinoxide : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010374/202101
English (EN) (155.83 KB - PDF)
български (BG) (268.24 KB - PDF)
español (ES) (191.99 KB - PDF)
čeština (CS) (280.96 KB - PDF)
dansk (DA) (223.99 KB - PDF)
Deutsch (DE) (216.77 KB - PDF)
eesti keel (ET) (214.13 KB - PDF)
ελληνικά (EL) (224.73 KB - PDF)
français (FR) (211.76 KB - PDF)
hrvatski (HR) (276.3 KB - PDF)
íslenska (IS) (212.6 KB - PDF)
italiano (IT) (217.23 KB - PDF)
latviešu valoda (LV) (242.01 KB - PDF)
lietuvių kalba (LT) (271.93 KB - PDF)
magyar (HU) (285.5 KB - PDF)
Malti (MT) (268.8 KB - PDF)
Nederlands (NL) (212.68 KB - PDF)
norsk (NO) (198.55 KB - PDF)
polski (PL) (282.87 KB - PDF)
português (PT) (197.69 KB - PDF)
română (RO) (272.98 KB - PDF)
slovenčina (SK) (233.71 KB - PDF)
slovenščina (SL) (252.9 KB - PDF)
Suomi (FI) (207.83 KB - PDF)
svenska (SV) (245.29 KB - PDF)